methionine has been researched along with rolipram in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houslay, MD; Pryde, JG; Shakur, Y | 1 |
1 other study(ies) available for methionine and rolipram
Article | Year |
---|---|
Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Amino Acid Sequence; Animals; Brain; Cell Line; Cell Membrane; Chlorocebus aethiops; Enzyme Stability; Kidney; Kinetics; Methionine; Phosphodiesterase Inhibitors; Protein Engineering; Pyrrolidinones; Rats; Recombinant Proteins; RNA, Messenger; Rolipram; Sequence Deletion; Thermodynamics; Transfection | 1993 |